Senior insider sale
Chief Operating Officer at ESPERION THERAPEUTICS, INC. — senior position signals high conviction
$246.8K
73.82K shares
What this filing means
KOENIG SHELDON L. plans to sell 73.82K shares of ESPERION THERAPEUTICS, INC. valued at approximately $246.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001959173-26-002423
Officer· Chief Operating Officer
Since Dec 2020
73.82K
Shares to sell
$246.8K
Approx. market value
25.58K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/16/2026
25.58KTotal acquired25.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/16/2026 | Restricted Stock Vesting Compensation | 25.58K | — |
| Total | 25.58K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
48.24K
Market value
$177.2K
12/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
25.58K
Market value
$69.6K
3/17/2026
Total
Units
73.82K
Value
$246.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/17/2025 | 48.24K | $177.2K | — | Completed |
| Planned — Approximate Date | ||||
3/17/2026 | 25.58K | $69.6K | NASDAQ | Planned |
| Total | 73.82K | $246.8K | ||